News | Solving Kids’ Cancer UK

29 July 2020 3 min read

First three months

Gail Jackson, CEO, launches her blog. Reflecting on personal resilience, our work and joining Solving Kids' Cancer as COVID hit.

A scientist in a lab coat and safety goggles operates advanced lab equipment, holding a tray of vials, in a well-equipped research laboratory.

21 July 2020 1 min read

Research update- July 2020

The impact of COVID-19 has been serious and will have long-lasting consequences for medical research in the UK, not least because so much of our medical research is funded by charities.

14 July 2020 1 min read

Supporting Decision Making - REDMAPP Study

The REDMAPP research study aims to develop a decision aid to support parents when their child has relapsed neuroblastoma by first gaining a greater understanding of how parents make a series of repeated treatment-related decisions.

19 May 2020 5 min read

Charities fund new clinical trial

Solving Kids’ Cancer, with Neuroblastoma UK, has awarded a grant of £609,762.40 to enable the SIOPEN High-Risk Neuroblastoma Clinical Trial 2 (HR-NBL2) to open in the UK, it is anticipated to open in early 2021.

A close-up black-and-white image of medical infusion pumps administering treatment, with labels visible, indicating precise infusion rates.

28 April 2020 1 min read

Research update - May 2020

The coronavirus pandemic has brought new challenges to our ongoing research programme, as we work with experts worldwide to bring more, better and less toxic treatment to children in the UK and beyond.

14 February 2020 1 min read

Watch brave Kira on Scotland Tonight

Kira Noble, supported by Solving Kids' Cancer throughout her cancer journey, appeared on Scotland Tonight on 13th February as STV followed her latest scan and results.

18 November 2019 3 min read

Grant awarded to identify markers of poor survival in high-risk neuroblastoma

Solving Kids’ Cancer Europe, Solving Kids' Cancer in New York, Oscar Knox Fund, Smiles for Stanley Fund and Merryn Lacy Trust have awarded a grant of $420,000.

A close-up of a person's hands holding a printed document in one hand and a pen in the other, at a desk with an open laptop in the background.

1 November 2019 4 min read

Outcome for children in the UK after high-risk neuroblastoma treatment

We explain the recent statement from the UK clinical community.

15 October 2019 2 min read

CCLG statement: Outcome after high-risk neuroblastoma treatment

SIOPEN, the UK National Cancer Research Institute Neuroblastoma Group and the CCLG Neuroblastoma Special Interest Group are committed to further improving the outcome for children with neuroblastoma.